Medtronic (MDT) Competitors

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, community ranking, earnings, dividends, analyst recommendations, valuation and media sentiment.

Which has higher earnings and valuation, ABT or MDT?

Abbott Laboratories has higher revenue and earnings than Medtronic. Abbott Laboratories is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$41.95B	5.27	$13.40B	$7.65	16.67
Medtronic	$33.20B	3.23	$3.68B	$3.29	25.39

Does the MarketBeat Community favor ABT or MDT?

Medtronic received 643 more outperform votes than Abbott Laboratories when rated by MarketBeat users. Likewise, 75.45% of users gave Medtronic an outperform vote while only 69.97% of users gave Abbott Laboratories an outperform vote.

Company	Underperform	Outperform
Abbott Laboratories	Outperform Votes 946 69.97%	Underperform Votes 406 30.03%
Medtronic	Outperform Votes 1589 75.45%	Underperform Votes 517 24.55%

Does the media refer more to ABT or MDT?

In the previous week, Medtronic had 1 more articles in the media than Abbott Laboratories. MarketBeat recorded 40 mentions for Medtronic and 39 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.41 beat Medtronic's score of 1.27 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	32 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	28 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Is ABT or MDT a better dividend stock?

Abbott Laboratories pays an annual dividend of $2.36 per share and has a dividend yield of 1.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.4%. Abbott Laboratories pays out 30.8% of its earnings in the form of a dividend. Medtronic pays out 85.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has raised its dividend for 54 consecutive years and Medtronic has raised its dividend for 48 consecutive years.

Which has more volatility & risk, ABT or MDT?

Abbott Laboratories has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of ABT or MDT?

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.2% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Is ABT or MDT more profitable?

Abbott Laboratories has a net margin of 31.95% compared to Medtronic's net margin of 12.83%. Abbott Laboratories' return on equity of 20.74% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	31.95%	20.74%	11.19%
Medtronic	12.83%	14.07%	7.70%

Do analysts rate ABT or MDT?

Abbott Laboratories presently has a consensus price target of $137.94, indicating a potential upside of 8.18%. Medtronic has a consensus price target of $96.14, indicating a potential upside of 15.09%. Given Medtronic's higher possible upside, analysts plainly believe Medtronic is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.84
Medtronic	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.44

Summary

Abbott Laboratories beats Medtronic on 14 of the 21 factors compared between the two stocks.